Mini-cognitive testing in patients with age-related macular degeneration

Retina

Volumn 34, Issue 5, 2014, Pages 868-873

  Al Salem, Khalil M ^a   Schaal, Shlomit ^b  

^a MUTAH UNIVERSITY   (Jordan)

^b University of Louisville School of Medicine   (United States)

Author keywords

Age related macular degeneration; Cognitive impairment; Mini cognitive screen test

Indexed keywords

ADULT; AGED; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMEDIATE TERM MEMORY; MAJOR CLINICAL STUDY; MALE; MEMORY; MINI COGNITIVE SCREENING TEST; NEUROLOGIC EXAMINATION; OPHTHALMOLOGY; RETINA MACULA AGE RELATED DEGENERATION; SCREENING TEST; SHORT TERM MEMORY; TIME PERCEPTION; COGNITION DISORDERS; COMPARATIVE STUDY; FLUORESCENCE ANGIOGRAPHY; GEOGRAPHIC ATROPHY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; VERY ELDERLY; WET MACULAR DEGENERATION;

AGED; AGED, 80 AND OVER; COGNITION DISORDERS; FEMALE; FLUORESCEIN ANGIOGRAPHY; GEOGRAPHIC ATROPHY; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; TOMOGRAPHY, OPTICAL COHERENCE; WET MACULAR DEGENERATION;

EID: 84899848160     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000006     Document Type: Article

References (44)

1. Jama JW, Launer LJ, Witteman JC, et al. Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. Am J Epidemiol 1996;144: 275-280.
2. Ortega RM, Requejo AM, Andres P, et al. Dietary intake and cognitive function in a group of elderly people. Am J Clin Nutr 1997;66:803-809.
3. Friedman DS, O'Colmain BJ, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004;122:564-572.
4. Guyer DR, Fine SL, Maguire MG, et al. Subfoveal choroidal neovascular membranes in age-related macular degeneration. Visual prognosis in eyes with relatively good initial visual acuity. Arch Ophthalmol 1986;104:702-705.
5. Wong TY, Chakravarthy U, Klein R, et al. The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-Analysis. Ophthalmology 2008;115:116-126.
6. Baker ML, Wang JJ, Rogers S, et al. Early age-related macular degeneration, cognitive function, and dementia: the Cardiovascular Health Study. Arch Ophthalmol 2009;127:667-673.
7. Dewji NN, Singer SJ. Genetic clues to Alzheimer's disease. Science 1996;271:159-160.
8. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183-194.
9. Roca-Santiago HM, Lago-Bouza JR, Millan-Calenti JC, Gomez-Ulla-Irazazabal F. [Alzheimer's disease and age-related macular degeneration]. Arch Soc Esp Oftalmol 2006;81:73-78.
10. Klaver CC, Ott A, Hofman A, et al. Is age-related maculopathy associated with Alzheimer's Disease? The Rotterdam Study. Am J Epidemiol 1999;150:963-968.
11. Wong TY, Klein R, Nieto FJ, et al. Is early age-related maculopathy related to cognitive function? The Atherosclerosis Risk in Communities Study. Am J Ophthalmol 2002;134: 828-835.
12. Borson S, Scanlan J, Brush M, et al. The mini-cog: a cognitive 'vital signs' measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry 2000;15:1021-1027.
13. Chen CY, Leung KK, Chen CY. A quick dementia screening tool for primary care physicians. Arch Gerontol Geriatr 2011; 53:100-103.
14. Alzheimer's Association, Thies W, Bleiler L. 2011 Alzheimer's disease facts and figures. Alzheimers Dement 2011;7:208-244.
15. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004;55:306-319.
16. Ohno-Matsui K. Parallel findings in age-related macular degeneration and Alzheimer's disease. Prog Retin Eye Res 2011;30:217-238.
17. Johnson LV, Leitner WP, Rivest AJ, et al. The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci U S A 2002;99:11830-11835.
18. Dentchev T, Milam AH, Lee VM, et al. Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas. Mol Vis 2003;9:184-190.
19. Donoso LA, Kim D, Frost A, et al. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2006;51:137-152.
20. Penfold PL, Madigan MC, Gillies MC, Provis JM. Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res 2001;20:385-414.
21. Cameron B, Landreth GE. Inflammation, microglia, and Alzheimer's disease. Neurobiol Dis 2010;37:503-509.
22. Mandrekar-Colucci S, Landreth GE. Microglia and inflammation in Alzheimer's disease. CNS Neurol Disord Drug Targets 2010;9:156-167.
23. Edwards AO, Ritter R III, Abel KJ, et al. Complement factor H polymorphism and age-related macular degeneration. Science 2005;308:421-424.
24. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005;308:419-421.
25. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005;308:385-389.
26. Zetterberg M, Landgren S, Andersson ME, et al. Association of complement factor H Y402H gene polymorphism with Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 2008;147B:720-726.
27. Song F, Poljak A, Smythe GA, Sachdev P. Plasma biomarkers for mild cognitive impairment and Alzheimer's disease. Brain Res Rev 2009;61:69-80.
28. Good PF, Werner P, Hsu A, et al. Evidence of neuronal oxidative damage in Alzheimer's disease. Am J Pathol 1996;149: 21-28.
29. Smith MA, Rottkamp CA, Nunomura A, et al. Oxidative stress in Alzheimer's disease. Biochim Biophys Acta 2000;1502: 139-144.
30. Butterfield DA, Boyd-Kimball D. Amyloid beta-peptide(1-42) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain. Brain Pathol 2004;14:426-432.
31. Bruban J, Glotin AL, Dinet V, et al. Amyloid-beta(1-42) alters structure and function of retinal pigmented epithelial cells. Aging Cell 2009;8:162-177.
32. Bruban J, Maoui A, Chalour N, et al. CCR2/CCL2-mediated inflammation protects photoreceptor cells from amyloid-betainduced apoptosis. Neurobiol Dis 2011;42:55-72.
33. Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, et al. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage 2011;54:S204-S217.
34. Emery VO. Alzheimer disease: are we intervening too late? Pro. J Neural Transm 2011;118:1361-1378.
35. Petersen RC. Early diagnosis of Alzheimer's disease: is MCI too late? Curr Alzheimer Res 2009;6:324-330.
36. Clarke PJ, Blount V, Colantonio A. Cognitive impairment predicts fatal incident stroke: findings from a national sample of older adults. J Am Geriatr Soc 2011;59:1490-1496.
37. St John PD, Montgomery PR. Cognitive impairment and life satisfaction in older adults. Int J Geriatr Psychiatry 2010;25:814-821.
38. Day S, Acquah K, Lee PP, et al. Medicare costs for neovascular age-related macular degeneration, 1994-2007. Am J Ophthalmol 2011;152:1014-1020.
39. Pouryamout L, Dams J, Wasem J, et al. Economic evaluation of treatment options in patients with Alzheimer's disease: a systematic review of cost-effectiveness analyses. Drugs 2012;72: 789-802.
40. Clemons TE, Rankin MW, McBee WL. Cognitive impairment in the Age-Related Eye Disease Study: AREDS report no. 16. Arch Ophthalmol 2006;124:537-543.
41. Rovner BW, Casten RJ, Leiby BE. Variability in depressive symptoms predicts cognitive decline in age-related macular degeneration. Am J Geriatr Psychiatry 2009;17:574-581.
42. Pham TQ, Kifley A, Mitchell P, Wang JJ. Relation of agerelated macular degeneration and cognitive impairment in an older population. Gerontology 2006;52:353-358.
43. Mejia-Arango S, Gutierrez LM. Prevalence and incidence rates of dementia and cognitive impairment no dementia in the mexican population: data from the mexican health and aging study. J Aging Health 2011;23:1050-1074.
44. Ong SY, Cheung CY, Li X, et al. Visual impairment, agerelated eye diseases, and cognitive function: the Singapore Malay Eye study. Arch Ophthalmol 2012;130:895-900.